During the past decade, Sanatorio de la Trinidad Mitre conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 4 clinical trials were completed. i.e. 44.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sanatorio de la Trinidad Mitre" #1 sponsor was "Actelion" with 4 trials, followed by "United Therapeutics" with 4 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Pharmasset" with 2 trials sponsored and "Argentinian Intensive Care Society" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sanatorio de la Trinidad Mitre" #1 collaborator was "AbCellera Biologics Inc." with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "International Childrens Medical Research Association, Switzerland." with 1 trials as a collaborator, "Shanghai Junshi Bioscience Co., Ltd." with 1 trials as a collaborator and "Vir Biotechnology, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Sanatorio de la Trinidad Mitre" are "Pulmonary Arterial Hypertension" (6 trials), "COVID-19" (2 trials), "Cardiovascular Diseases" (2 trials), "Chronic Hepatitis" (2 trials) and "Chronic Thromboembolic Pulmonary Hypertension" (2 trials). Many other conditions were trialed in "Sanatorio de la Trinidad Mitre" in a lesser frequency.

Most popular intervention types in "Sanatorio de la Trinidad Mitre" are "Drug" (12 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Adefovir" (2 trials), "Clevudine" (2 trials), "Ralinepag" (2 trials) and "Bamlanivimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sanatorio de la Trinidad Mitre" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Sanatorio de la Trinidad Mitre". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 8 completed trials in Sanatorio de la Trinidad Mitre, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Sanatorio de la Trinidad Mitre, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".